In what one side is billing as the final act in the krill wars in North America, the US Patent and Trademark Office has ruled to uphold certain claims of a longstanding patent held by Neptune Technologies and Bioressources. But the handle of the buried...
Challenging ingredients like krill oil and fish oil are driving demand for Capsugel’s Licaps liquid-filled hard capsule technology, says the company, as Healthy Directions becomes the latest manufacturer to use the capsules for its Krill Omega Defense...
Norwegian firm Olympic Seafood AS has entered in to a research collaboration with two universities to use novel ‘omics’ technologies to investigate the potential health benefits of krill oil supplements.
Despite recent negative publicity surrounding omega-3s, a new survey has found that practitioners who commonly recommend supplements to their patients still strongly support the use of omega-3s.
Neptune Technologies and Bioressources absorbed a steep loss in the first quarter of its fiscal year as the company nears the end of its recovery from an explosion and fire that destroyed its lone production plant. Net loss for the quarter was $5.3 million,...
Krill oil supplementation to a high-fat (Western) diet was effective in reducing plasma lipid levels, with the effects via a different mechanism to fish oil, says a new study with lab mice.
The end of the krill wars is the begining of a new chapter in the history of the omega 3s market, said Tim De Haas, of krill supplier Aker Biomarine. It’s good news not just for the krill oil suppliers themselves, but for the category as a whole.
The long-running krill oil patent dispute between Canada’s Neptune Technologies & Bioressources and Israel-based Enzymotec Ltd. has come to an end, with the firms signing a final and binding patent infringement settlement and license agreement.
The krill sector, a hotbed of news in recent weeks, could acquire a new production player after a successful test aboard a fishing vessel of a new extraction technique by Tharos Ltd., a Chilean firm that has worked on the technology end of the business...
In its first earnings statement since the conclusion of its long-standing intellectual property battle with its krill competitors, Neptune CFO Andre Godin said the company is coming to the end of the of a difficult period.
Aker BioMarine, one of the world’s biggest of krill-derived omega-3 phospholipid products, has achieved New Food Raw Material status for Superba krill in China meaning it can now enter the potentially lucrative Chinese market.
Some things have seemed immutable: Death. Taxes. The Krill Wars. But the latter has (mostly) fallen off that list with the announcement this morning that fierce competitors Neptune Technologies & Bioressources and Aker BioMarine have reached an 11th-hour...
Supplements containing krill oil may be more effective at raising levels of the omega-3 fatty acids EPA and DHA that accumulate in the red blood cells – the omega-3 index – than fish oil, says a new study from Enzymotec Ltd.
The lengthy court battles in the krill sector took a new turn when the category’s newest entrant, Rimfrost, settled a patent dispute and entered into a supply agreement with Neptune Technologies and Bioressources, the company that first brought krill...
Daily consumption of krill oil may boost learning and working memory in lab animals, and display antidepressant-like effects, according to a new study from Aker BioMarine.
Supplementing the diet with fish oil and krill oil can beneficially change cholesterol levels, but only krill oil was found to reduce triacylglycerol levels, suggests new data from lab animals.
Norwegian krill ingredient supplier Olympic Seafood AS has kicked off a new research partnership to investigate the fundamental science behind krill phospholipids.
Neptune Technologies & Bioressources has secured “new and firm orders amounting to US$25M for calendar year 2013” for its krill oil, driven by strong demand from Asia.
Canadian krill oil firm Neptune Technologies & Bioressources has posted a 31% surge in sales in its nutraceutical business in the final quarter of fiscal 2012, and a 15% rise in sales in this division over the full year.
Nearly four out of 10 (37%) US supplement users say they would rather take something other than fish oil as an omega-3 supplement, according to a new survey.
Suggestions by Aker Biomarine that Neptune Technologies and Bioressources misrepresented the novelty of the inventions claimed in its newly-granted krill oil patent are “baseless”, Neptune bosses have insisted.
Neptune Technologies & Bioressources has bolstered its intellectual property portfolio further after securing a new US patent (No. 8,057,825) awarding it the exclusive use of krill extracts in the US as a method for reducing cholesterol, platelet...
Israeli nutritional lipids giant Enzymotec has weighed into the patent infringement row engulfing the krill oil industry with a statement from its boss declaring rival Neptune’s new US patent for marine phospholipids ‘invalid’ and ‘unenforceable’ and...
The nascent but rapidly growing krill sector is set to match or exceed 10+% point growth forecast for the entire omega-3 sector, even as public awareness remains relatively low and sustainability questions – justified or otherwise – refuse to go away.
Supplementing a high fat diet with krill oil may activate receptors that affect appetite and energy balance, suggest new findings from a mouse study with potential implications for obesity.
Daily supplements of krill oil may reduce cholesterol levels by 33 percent, and improve liver triglyceride levels, with results superior to fish oil, according to data from a rat study.
Aker BioMarine has signed its first agreement to supply a Chinese supplement maker with its branded krill oil, in a deal that paves the way for a new category in the country.
Omega-3-rich krill oil may combat metabolic symptoms including raised fat levels in the heart and liver in obese individuals, says a new study partly supported by Aker Biomarine.
Israeli supplier Enzymotec has implemented a programme to test for and publicise levels for two chemicals produced by marine life and which produce the "foul odour of sea food”.
Zurich-based DKSH has announced an expansion of its agreement with Israel’s Enzymotec to include the distribution of krill oil, as the companies continue their ‘very successful partnership’.
Aker’s krill oil has similar effects as fish oil on serum lipids, markers of oxidative stress and inflammation, but with lower doses of EPA and DHA, a new study in healthy volunteers has concluded.
A detailed description of the fatty acid profile of krill oil has revealed a high content of phospholipid omega-3 fatty acid, and may aid future product development.
Daily supplements of krill oil may reduce the symptoms of arthritis, with the benefits linked to the omega-3 and antioxidant content of the ingredient, suggests a new study.
Krill oil as a food ingredient has received another boost in Europe, with Israeli firm Enzymotec announcing its krill product line has obtained Novel Food status.
Omega-3s sourced from krill are more effective than fish oil in combating some metabolic symptoms including raised fat levels in the heart and liver in obese individuals, according to Italian researchers.
A European supplier of health supplements says that the launch of a branded Krill oil product onto the Norwegian market will be a key launch for 2009 ahead of potential further rollouts in Europe, the US and Asia.
Israeli ingredient firm Enzymotec has opened a US subsidiary, which
the firm hopes will help it improve service to customers and
penetrate new areas of activity - particularly functional foods.
Israeli company Enzymotec has obtained GRAS status for its krill
oil, which the company hopes will allow it to commercialize the
ingredient for use in functional foods in the US.
Enzymotec has announced its entry into the krill oil market, going
head to head with market leader Neptune Krill Oil and planning
clinical research into the health benefits of its ingredient.
Neptune Technologies & Bioressources has announced the closing
of a $4.5mn private placement of common shares, which is designed
to help accelerate its business strategy and boost R&D efforts.
Neptune Technologies and Bioressources is planning a private
placement of common shares that will raise between C$3m and $4.5m
to help accelerate its business strategy and boost R&D efforts.
Canadian Neptune Technologies & Bioressources has signed a deal
with Pharmanex that will dramatically widen the distribution of
marine biomass extract Neptune Krill Oil (NKO) over the coming
year.